tirzepatide pregnancy planning discontinue how long before conception label TrimRX tirzepatide pregnancy discontinue before conception
Description
Tirzepatide is a novel once-weekly injectable that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously
More serious adverse effects include pancreatitis, gallbladder disease, and hypoglycemia when used with insulin or sulfonylureas
Weeks 1 through 4: Reduce to 12.5 mg weekly
Regardless of the outcome of these trials, its important to know that not everyone will have the same personal results
